- Yunkang Group swung to net profit of RMB 3.9 million in 2025 from a net loss a year earlier.
- Revenue fell 15.5% to RMB 600 million.
- Operating income turned positive at RMB 33 million.
- Turnaround was attributed to lower selling and administrative expenses, reduced net finance costs, and reversal of prior-year credit impairment losses on trade receivables.
- Business updates included expanding a three-hub delivery network in Guangzhou, Chengdu, and Hefei, scaling AI-assisted diagnostics, and rolling out “ZhiYun” medical AI model pilots with healthcare partners.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yunkang Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260331-12081513), on March 31, 2026, and is solely responsible for the information contained therein.
Comments